Anaptysbio ANAB
NASDAQ ANAB
$48.53 -0.10 (-0.21%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) Price to FCF (2021 - 2026)

Updated

Anaptysbio's Price to FCF was 243.43 in Q1 2026, up 427.1% from the prior quarter.

Analysis

Anaptysbio (ANAB) Price to FCF (2021 - 2026) Analysis & Trends

For FY2025, Price to FCF at Anaptysbio came in at 46.18.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Anaptysbio 1.41 Bn 296.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 243.43
Dec 31, 2025 46.18
Sep 30, 2021 32.45
Jun 30, 2021 88.28
API Access

Anaptysbio Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=ANAB&period=max&api_key=YOUR_API_KEY